Precision Biomarkers to Detect Brain Injury in Active-Duty United States Special Operations Forces With Repeated Blast Exposure
Recruiting now · Phase 2
Conditions studied: Blast Injury
In brief
This is a 4-year, longitudinal study of 100 active-duty Navy SEALs. The goal of the study is to determine whether repeated blast exposure affects SEAL brain health and to develop an initial diagnostic testing protocol that detects repeated blast brain injury.
Key facts
- Study ID
- NCT07131475
- Run by
- Massachusetts General Hospital
- People needed
- 100
- Starts
- 2025-10-14
- Expected to finish
- 2029-08-31
- Last updated by the study team
- 2025-10-31
Who can join
Age: 18 and older, up to 50. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Active-duty Navy SEAL Service Member
- Early career SEAL (0-2 years) or mid-late career SEAL (10-15 years)
- Age 18-50 years
- Males, regardless of race or ethnicity
You may not qualify if…
- History of moderate or severe TBI
- History of major neurological disorder
- Untreated or unstable severe psychiatric condition
- Current severe medical condition that requires long-term treatment
- Any condition that may cause undue risk to the participant or create a logistical contraindication
- MRI contraindication
- PET contraindication
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.